3NOC image
Deposition Date 2010-06-25
Release Date 2011-05-18
Last Version Date 2024-10-16
Entry Detail
PDB ID:
3NOC
Title:
Designed ankyrin repeat protein (DARPin) binders to AcrB: Plasticity of the Interface
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.70 Å
R-Value Free:
0.26
R-Value Work:
0.24
R-Value Observed:
0.24
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Acriflavine resistance protein B
Gene (Uniprot):acrB
Chain IDs:A, B, C
Chain Length:1049
Number of Molecules:3
Biological Source:Escherichia coli
Polymer Type:polypeptide(L)
Molecule:Designed ankyrin repeat protein
Chain IDs:D, E
Chain Length:169
Number of Molecules:2
Biological Source:synthetic construct
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
FME A MET N-FORMYLMETHIONINE
Primary Citation
Designed ankyrin repeat protein binders for the crystallization of AcrB: Plasticity of the dominant interface
J.Struct.Biol. 174 269 281 (2011)
PMID: 21296164 DOI: 10.1016/j.jsb.2011.01.014

Abstact

The formation of well-diffracting crystals is a major bottleneck in structural analysis of membrane proteins by X-ray crystallography. One approach to improve crystal quality is the use of DARPins as crystallization chaperones. Here, we present a detailed analysis of the interaction between DARPins and the integral membrane protein AcrB. We find that binders selected in vitro by ribosome display share a common epitope. The comparative analysis of three crystal structures of AcrB-DARPin complexes allowed us to study the plasticity of the interaction with this dominant binding site. Seemingly redundant AcrB-DARPin crystals show substantially different diffraction quality as a result of subtle differences in the binding geometry. This work exemplifies the importance to screen a number of crystallization chaperones to obtain optimal diffraction data. Crystallographic analysis is complemented by biophysical characterization of nine AcrB binders. We observe that small variations in the interface can lead to differing behavior of the DARPins with regards to affinity, stoichiometry of the complexes and specificity for their target.

Legend

Protein

Chemical

Disease

Primary Citation of related structures